AstraZeneca PLC
Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis.
企業詳細
YOUFIRE JapanYOUFIRE JapanYOUFIRE JapanEndoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis.
企業詳細Short-term Pre-OPerative Durvalumab (MEDI 4736) in Early Small Triple Negative Breast Cancer Patients (POP-Durva)
企業詳細Barriers and Facilitators of Persistence With Adjuvant Osimertinib
企業詳細The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
企業詳細Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients
企業詳細Carotid Intraplaque Neovascularization Combined With Stress Echo
企業詳細A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD
企業詳細A Study of Raludotatug Deruxtecan (R-DXd) in People With Gastrointestinal Cancers (MK-5909-005)
企業詳細A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006)
企業詳細A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity
企業詳細A Study of SPY002-091 in Healthy Volunteers
企業詳細Study Evaluating AZD7798 for Treatment in Crohn's Disease Patients With an Ileostomy
企業詳細Prospective Observational Multicenter Study of Patients With AH and CKD Markers in Kazakhstan (PROGRESS-CKD)
企業詳細Axitinib + Ipilimumab in Advanced Melanoma
企業詳細Avelumab Program Rollover Study
企業詳細Substudy 03A: A Study of Immune and Targeted Combination Therapies in Participants With First Line (1L) Renal Cell Carcinoma (MK-3475-03A)
企業詳細Substudy 03B: A Study of Immune and Targeted Combination Therapies in Participants With Second Line Plus (2L+) Renal Cell Carcinoma (MK-3475-03B/KEYMAKER-U03)
企業詳細A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy
企業詳細A Study to Learn How Different Amounts of the Study Medicine Called PF-07999415 Are Tolerated and Act in the Body in Healthy Adults
企業詳細A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors
企業詳細A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease
企業詳細Effect of Maridebart Cafraglutide on the Heart's Electrical Activity
企業詳細A Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLC
企業詳細A Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy Participants
企業詳細Selumetinib and Olaparib in Solid Tumors
企業詳細Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GB-7624 in Healthy Adult Participants
企業詳細ONC-392 and Pembrolizumab in Platinum Resistant Ovarian Cancer
企業詳細MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
企業詳細A Study to Learn About Study Medicine Lorlatinib, as a First-line Treatment in Chinese Adults With ALK-positive a/mNSCLC
企業詳細Acalabrutinib and Durvalumab in Primary and Secondary Central Nervous System Lymphoma
企業詳細Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)
企業詳細A Real-World Assessment of the Demographic, Clinical Characteristics and Outcomes of a Brazilian Cohort of Previously Untreated Extensive Stage-Small Cell Lung Cancer Receiving Durvalumab Combined With Platinum-Etoposide in (ES-SCLC) in Brazil
企業詳細Boosting Regional Integration for COP D Care Through Guided Implementation and Audit of Post Exacerbation Transition Bundle
企業詳細A Two-armed Real-world Study of Ozempic (OW Semaglutide) to Evaluate Its Adherence and Persistence Compared With Other Anti-diabetic Drugs Among Adult T2DM Patients in China
企業詳細A Study to Learn Safety and Immune Response to Study Vaccine -RSVpreF in Adults at High Risk of Severe RSV Disease.
企業詳細A Study to Compare the Blood Levels of Two Dosage Formulations of the Study Medicine in Healthy Adults
企業詳細A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors
企業詳細Hypofractionated Whole-Pelvis Radiotherapy (WPRT) vs Conventionally-Fractionated WPRT in Prostate Cancer
企業詳細A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
企業詳細A Mass Balance Study of Oral [14C] ABBV-932 in Healthy Adult Male Participants
企業詳細A Retrospective Study to Evaluate Treat-to-Target and Disease Modification in Adult Participants With Crohn's Disease and Ulcerative Colitis in Real World Setting
企業詳細A Study to Assess the Adverse Events and How Bretisilocin Intramuscular Injection Moves Through the Body of Healthy Adult Participants
企業詳細A Study to Evaluate How Multiple Doses of Itraconazole Interacts With Nacresertib in Healthy Adult Participants
企業詳細Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
企業詳細Radiation Therapy in Combination With Durvalumab for People With Pancreatic Cancer
企業詳細Study Evaluating the Safety and Efficacy of MEDI5752 in Combination With Stereotactic Radiotherapy in Patients With Metastatic Sarcoma
企業詳細Impact of Long-acting Bronchodilator- -Corticoid Inhaled Therapy on Ventilation, Lung Function and Breathlessness
企業詳細Explore the Efficacy and Mechanism of Action of Tezepelumab in Eosinophilic Granulomatosis With Polyangiitis
企業詳細Maintenance Durvalumab (MEDI4736) and Olaparib (AZD2281) After Standard 1st Line Treatment (Carboplatin/Cisplatin, Etoposide, Durvalumab) in HRD Positive Extensive Disease (ED) Small-cell Lung Cancer (SCLC)
企業詳細Determining Efficacy of an Artificial Intelligence-based System for Heart Failure Detection Through Interpretation of Electrocardiograms (DECISION)
企業詳細Characterizing the Human Airway Immune Response to FluMist Vaccination
企業詳細Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
企業詳細Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection
企業詳細Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients
企業詳細A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
企業詳細A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)
企業詳細A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)
企業詳細A Study to Compare Two Different Sleep Tests in Participants With No Symptoms or Early Symptoms of Alzheimer's Disease
企業詳細A Study of Food Effect on Tersolisib (LY4064809) in Healthy Participants
企業詳細PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer
企業詳細Test-retest Study With [18F]FBB in Cardiac Amyloidosis
企業詳細Combination Study of Guadecitabine/ASTX727 and Pembrolizumab
企業詳細Study of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC)
企業詳細Phase II Trial of Trilaciclib, Pembrolizumab, Gemcitabine and Carboplatin in Metastatic Triple-Negative Breast Cancer
企業詳細Don't be Late! Postponing Cognitive Decline and Preventing Early Unemployment in People With Multiple Sclerosis
企業詳細Characterization, Health Resource Utilization and Biomarkers in Early-stage
企業詳細The Intelligent Diabetes TelemonitoRing Using Decision Support to Treat Patients on Insulin Therapy
企業詳細ITP Registry and Accompanying Biospecimen Collection
企業詳細Role of Immune System in Obesity-related Inflammation and Cardiometabolic Risk
企業詳細Rimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the US
企業詳細MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
企業詳細HIV Prevention With PrEP Among People on Opioid Replacement Therapy
企業詳細A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG
企業詳細De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Transplant Recipients
企業詳細A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
企業詳細TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)
企業詳細Phase 2 DoceRamPem for Patients With Metastatic or Recurrent NSCLC Who Progressed on Platinum-Doublet and PD-1/PD-L1 Blockade
企業詳細A Clinical Study of MK-4082 in Healthy Overweight Participants (MK-4082-002)
企業詳細A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension
企業詳細Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose.
企業詳細A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
企業詳細A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)
企業詳細A Study of MK-7240 in Healthy Participants (MK-7240-009)
企業詳細A Research Study to Compare Blood Levels of Two Different Versions of Cagrilintide in Adults With Excess Body Weight
企業詳細A Study to Learn How Different Forms of the Study Medicine Called PF-08049820 Are Absorbed and Eliminated in Healthy Adults
企業詳細A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)
企業詳細A Clinical Study of MK-7262 and Enlicitide in Healthy Participants (MK-7262-003)
企業詳細A Phase I, Cross-over Study Comparing the Relative Bioavailability of Laroprovstat Plus Ezetimibe Fixed Combination Drug Products Versus Their Single Therapy Products in Healthy Adults
企業詳細A Study to Learn About How Food Affects the Uptake of Study Medicine Prifetrastat Into the Blood in Healthy Adults
企業詳細A Study to See the Effect of NNC0194-0499 Alone or in Combination With Semaglutide on Blood Sugar Control in People Living With Type 1 Diabetes
企業詳細A Study to Learn How the Study Medicine Called Etrasimod is Taken up Into Blood and Breastmilk of Healthy Breastfeeding Women
企業詳細A Study of Nemtabrutinib in Participants With Moderate Hepatic Impairment (MK-1026-015)
企業詳細Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)
企業詳細A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes
企業詳細A Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234
企業詳細A Study to Learn How the Study Medicine Called PF-08653944 is Taken up Into the Blood in Adults With Overweight or Obesity
企業詳細A Study to Learn About Somatrogon in Patients With Pediatric Growth Hormone Deficiency (p GHD) in India.
企業詳細A Study of Belzutifan (MK-6482) in Combination With Palbociclib Versus Belzutifan Monotherapy in Participants With Advanced Renal Cell Carcinoma (MK-6482-024/LITESPARK-024)
企業詳細A Clinical Trial of MK-1403 in Healthy Participants (MK-1403-007)
企業詳細Korean Post-marketing Surveillance for Xeljanz XR
企業詳細Acalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Other Indolent Non-Hodgkin Lymphomas
企業詳細A Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of AZD1613 in Healthy Participants.
企業詳細Pembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer
企業詳細Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
企業詳細Korean Post-marketing Surveillance Ngenla® Pre-filled Pen Injection for the Treatment of Pediatric Patients With Growth Disturbance Due to Insufficient Secretion of Growth Hormone
企業詳細Can Stories Encourage the Elderly to Vaccinate? Combining Viewer-tailored Personal Narrative Videos With Informational Videos to Improve Vaccine Uptake Among Older Adults
企業詳細A Research Study on How NNC0638-0355, a New Medicine, Works in People Living With Overweight or Obesity
企業詳細A Study to Investigate the Effects of AZD0901 Monotherapy in Adult Participants With 2L+ Advanced or Metastatic Gastric or GEJ Adenocarcinoma Expressing CLDN18.2
企業詳細A Clinical Trial of MK-4082 in Healthy Participants (MK-4082-005)
企業詳細Study for Assessing the Prevalence of Airflow Limitation in Outpatients With History of Smoking Attending Cardiology Clinics
企業詳細Observational Study on the Prevalence and Risk Factors of Patients With Hyperkalaemia in Brazil
企業詳細Anti-CEACAM5 ADC Precemtabart Tocentecan (M9140) in Chinese Participants With Solid Tumors
企業詳細Adjuvant Palbociclib in Elderly Patients With Breast Cancer
企業詳細A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
企業詳細Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors
企業詳細A Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Erythematosus (CLE)
企業詳細Genetic Testing in Guiding Treatment for Patients With Brain Metastases
企業詳細A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA)
企業詳細A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
企業詳細Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)
企業詳細
